Skip to content
Valcreate PMS
  • About Us
  • Investment Approach
  • Investment Options
    • Valcreate Growing India
    • IME Concentrated Microtrends
    • Valcreate Life Sciences & Speciality
    • IME Digital Disruption
  • Media
    • Blog
    • Media Interviews
    • Press Articles
  • Contact Us

Media Publication: Business Today

These 14 PMS schemes delivered over 70% return to rich investors in 1 year; now own these stocks

100% return in 20 months! How stocks like Zomato, Policybazaar helped a digital disruption PMS deliver solid returns to HNIs

‘Rest of Middle East may rely on India’: How Israel-Hamas war will impact Indian pharma exports

What Lies Ahead For Investors

Article on Alkyl Amines in Business Today Magazine

Biocon’s subsidiary Syngene’s shares drop 12% in 2022; here’s what management and analysts have to say

With Covid gone as a money spinner, what are companies like Cipla, Sun Pharma and Dr Reddy’s looking at?

The pharma sector presents a study in contrast; here’s why

Why is Temasek-Manipal Health Enterprises deal ‘premium’?

Rajesh Pherwani on Reliance Life Sciences

(c) Valcreate Investment Managers LLP. All Rights Reserved | Downloads | Complaints

© 2025 Valcreate PMS • Built with GeneratePress